Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE2
Sponsor: Dana-Farber Cancer Institute
Condition: Melanoma (Skin)
NCT00085397
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.